1:58:28 PM PDT - Monday, September 20th, 2021

U.S. FDA declines emergency use approval for Humanigen’s COVID-19 drug  

By Editor - Wed Sep 08, 10:20 pm

The U.S. Food and Drug Administration declined Humanigen Inc's request for emergency use authorization of its lenzilumab drug to treat newly hospitalized COVID-19 patients, the company said on Thursday. “In its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19,” the company said in a statement.

View post:

U.S. FDA declines emergency use approval for Humanigen’s COVID-19 drug

Leave a Reply

You must sign in to post a comment.